Loading…

The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells

Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology 2012-11, Vol.42 (11), p.2889-2900
Main Authors: Zhan, Yifan, Vega‐Ramos, Javier, Carrington, Emma M., Villadangos, Jose A., Lew, Andrew M., Xu, Yuekang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3
cites cdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3
container_end_page 2900
container_issue 11
container_start_page 2889
container_title European journal of immunology
container_volume 42
creator Zhan, Yifan
Vega‐Ramos, Javier
Carrington, Emma M.
Villadangos, Jose A.
Lew, Andrew M.
Xu, Yuekang
description Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.
doi_str_mv 10.1002/eji.201242477
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1443378446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2824341081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</originalsourceid><addsrcrecordid>eNqF0c9u1DAQBnALgehSOHJFlrj00LSe8cROjmjVlqKiHihnK38mIksSL3YC2lsfoc_YJ8HVlh44wMkH__xpPJ8Qb0GdgFJ4ypv-BBUgIVn7TKwgR8gICJ6LlVJAGZaFOhCvYtwopUqTly_FAWKhjClhJdzNN5b91A3VOFazDzvZ7Gb_vZ_4WF58vr-9W385P5bVMHOIck625Z88-O3I01wN0i9z40eWvpPjEtKrdD-1oZ_7RjY8DPG1eNFVQ-Q3j-eh-Hp-drP-mF1dX1yuP1xlDWkDWQ6lbtnYUmPNigwWYAlVYcoaauhM23QFaW6A8haLrrJtl9eK0BaMdQ6sD8XRPncb_I-F4-zGPj5MUE3sl-iASGtbEJn_07RMm-cGbaLv_6Ibv4QpfSSp0hJoUJhUtldN8DEG7tw29GMVdg6UeyjJpZLcU0nJv3tMXeqR2yf9p5UEcA9-9QPv_p3mzj5dIgHo39V2muc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1197413102</pqid></control><display><type>article</type><title>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Zhan, Yifan ; Vega‐Ramos, Javier ; Carrington, Emma M. ; Villadangos, Jose A. ; Lew, Andrew M. ; Xu, Yuekang</creator><creatorcontrib>Zhan, Yifan ; Vega‐Ramos, Javier ; Carrington, Emma M. ; Villadangos, Jose A. ; Lew, Andrew M. ; Xu, Yuekang</creatorcontrib><description>Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.201242477</identifier><identifier>PMID: 22806691</identifier><identifier>CODEN: EJIMAF</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Animals ; Antigen Presentation - immunology ; Cell Differentiation - immunology ; Cytokines ; Dendritic Cells - cytology ; Dendritic Cells - immunology ; Dendritic cells and differentiation ; Flow Cytometry ; Flt3L ; fms-Like Tyrosine Kinase 3 - immunology ; GM‐CSF ; Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology ; Inflammation - immunology ; Inflammation - pathology ; Interleukin-10 - immunology ; Interleukin-12 - immunology ; Membrane Proteins - immunology ; Membrane Proteins - pharmacology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Transgenic ; Reactive Oxygen Species - immunology ; Recombinant Proteins - pharmacology ; Tumor Necrosis Factor-alpha - immunology</subject><ispartof>European journal of immunology, 2012-11, Vol.42 (11), p.2889-2900</ispartof><rights>2012 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</citedby><cites>FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22806691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhan, Yifan</creatorcontrib><creatorcontrib>Vega‐Ramos, Javier</creatorcontrib><creatorcontrib>Carrington, Emma M.</creatorcontrib><creatorcontrib>Villadangos, Jose A.</creatorcontrib><creatorcontrib>Lew, Andrew M.</creatorcontrib><creatorcontrib>Xu, Yuekang</creatorcontrib><title>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.</description><subject>Animals</subject><subject>Antigen Presentation - immunology</subject><subject>Cell Differentiation - immunology</subject><subject>Cytokines</subject><subject>Dendritic Cells - cytology</subject><subject>Dendritic Cells - immunology</subject><subject>Dendritic cells and differentiation</subject><subject>Flow Cytometry</subject><subject>Flt3L</subject><subject>fms-Like Tyrosine Kinase 3 - immunology</subject><subject>GM‐CSF</subject><subject>Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology</subject><subject>Inflammation - immunology</subject><subject>Inflammation - pathology</subject><subject>Interleukin-10 - immunology</subject><subject>Interleukin-12 - immunology</subject><subject>Membrane Proteins - immunology</subject><subject>Membrane Proteins - pharmacology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Reactive Oxygen Species - immunology</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqF0c9u1DAQBnALgehSOHJFlrj00LSe8cROjmjVlqKiHihnK38mIksSL3YC2lsfoc_YJ8HVlh44wMkH__xpPJ8Qb0GdgFJ4ypv-BBUgIVn7TKwgR8gICJ6LlVJAGZaFOhCvYtwopUqTly_FAWKhjClhJdzNN5b91A3VOFazDzvZ7Gb_vZ_4WF58vr-9W385P5bVMHOIck625Z88-O3I01wN0i9z40eWvpPjEtKrdD-1oZ_7RjY8DPG1eNFVQ-Q3j-eh-Hp-drP-mF1dX1yuP1xlDWkDWQ6lbtnYUmPNigwWYAlVYcoaauhM23QFaW6A8haLrrJtl9eK0BaMdQ6sD8XRPncb_I-F4-zGPj5MUE3sl-iASGtbEJn_07RMm-cGbaLv_6Ibv4QpfSSp0hJoUJhUtldN8DEG7tw29GMVdg6UeyjJpZLcU0nJv3tMXeqR2yf9p5UEcA9-9QPv_p3mzj5dIgHo39V2muc</recordid><startdate>201211</startdate><enddate>201211</enddate><creator>Zhan, Yifan</creator><creator>Vega‐Ramos, Javier</creator><creator>Carrington, Emma M.</creator><creator>Villadangos, Jose A.</creator><creator>Lew, Andrew M.</creator><creator>Xu, Yuekang</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201211</creationdate><title>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</title><author>Zhan, Yifan ; Vega‐Ramos, Javier ; Carrington, Emma M. ; Villadangos, Jose A. ; Lew, Andrew M. ; Xu, Yuekang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Antigen Presentation - immunology</topic><topic>Cell Differentiation - immunology</topic><topic>Cytokines</topic><topic>Dendritic Cells - cytology</topic><topic>Dendritic Cells - immunology</topic><topic>Dendritic cells and differentiation</topic><topic>Flow Cytometry</topic><topic>Flt3L</topic><topic>fms-Like Tyrosine Kinase 3 - immunology</topic><topic>GM‐CSF</topic><topic>Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology</topic><topic>Inflammation - immunology</topic><topic>Inflammation - pathology</topic><topic>Interleukin-10 - immunology</topic><topic>Interleukin-12 - immunology</topic><topic>Membrane Proteins - immunology</topic><topic>Membrane Proteins - pharmacology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Reactive Oxygen Species - immunology</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhan, Yifan</creatorcontrib><creatorcontrib>Vega‐Ramos, Javier</creatorcontrib><creatorcontrib>Carrington, Emma M.</creatorcontrib><creatorcontrib>Villadangos, Jose A.</creatorcontrib><creatorcontrib>Lew, Andrew M.</creatorcontrib><creatorcontrib>Xu, Yuekang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhan, Yifan</au><au>Vega‐Ramos, Javier</au><au>Carrington, Emma M.</au><au>Villadangos, Jose A.</au><au>Lew, Andrew M.</au><au>Xu, Yuekang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2012-11</date><risdate>2012</risdate><volume>42</volume><issue>11</issue><spage>2889</spage><epage>2900</epage><pages>2889-2900</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><coden>EJIMAF</coden><abstract>Fms‐like tyrosine kinase 3 ligand (Flt3L) is a major cytokine that drives development of dendritic cells (DCs) under steady state, whereas GM‐CSF becomes a prominent influence on differentiation during inflammation. The influence GM‐CSF exerts on Flt3L‐induced DC development has not been thoroughly examined. Here, we report that GM‐CSF alters Flt3L‐induced DC development. When BM cells were cultured with both Flt3L and GM‐CSF, few CD8+ equivalent DCs or plasmacytoid DCs developed compared to cultures supplemented with Flt3L alone. The disappearance of these two cell subsets in GM‐CSF + Flt3L culture was not a result of simple inhibition of their development, but a diversion of the original differentiation trajectory to form a new cell population. As a consequence, both DC progeny and their functions were altered. The effect of GM‐CSF on DC subset development was confirmed in vivo. First, the CD8+ DC numbers were increased under GM‐CSF deficiency (when either GM‐CSF or its receptor was ablated). Second, this population was decreased under GM‐CSF hyperexpression (by transgenesis or by Listeria infection). Our finding that GM‐CSF dominantly changes the regulation of DC development in vitro and in vivo has important implications for inflammatory diseases or GM‐CSF therapy.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>22806691</pmid><doi>10.1002/eji.201242477</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 2012-11, Vol.42 (11), p.2889-2900
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_1443378446
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Antigen Presentation - immunology
Cell Differentiation - immunology
Cytokines
Dendritic Cells - cytology
Dendritic Cells - immunology
Dendritic cells and differentiation
Flow Cytometry
Flt3L
fms-Like Tyrosine Kinase 3 - immunology
GM‐CSF
Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology
Inflammation - immunology
Inflammation - pathology
Interleukin-10 - immunology
Interleukin-12 - immunology
Membrane Proteins - immunology
Membrane Proteins - pharmacology
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Reactive Oxygen Species - immunology
Recombinant Proteins - pharmacology
Tumor Necrosis Factor-alpha - immunology
title The inflammatory cytokine, GM‐CSF, alters the developmental outcome of murine dendritic cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A34%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20inflammatory%20cytokine,%20GM%E2%80%90CSF,%20alters%20the%20developmental%20outcome%20of%20murine%20dendritic%20cells&rft.jtitle=European%20journal%20of%20immunology&rft.au=Zhan,%20Yifan&rft.date=2012-11&rft.volume=42&rft.issue=11&rft.spage=2889&rft.epage=2900&rft.pages=2889-2900&rft.issn=0014-2980&rft.eissn=1521-4141&rft.coden=EJIMAF&rft_id=info:doi/10.1002/eji.201242477&rft_dat=%3Cproquest_cross%3E2824341081%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4361-5193de67932be0462817420869b1b1f6dcf843ec145d28fa7df5b04278e2b51e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1197413102&rft_id=info:pmid/22806691&rfr_iscdi=true